About Codex DNA
Synthetic DNA on demand
Codex DNA is on a mission to empower scientific researchers in both academic and commercial settings with the hardware, software, materials, and methodologies required to rapidly and accurately write large quantities of synthetic genes. To, in effect, build biology.
We are decentralizing DNA synthesis, with the world's most innovative portfolio of synthetic biology technologies.
Our gene synthesis portfolio reduces the turnaround time for synthesizing workflows from weeks and months to days and hours, and includes the BioXp™ system, DNA services, Gibson Assembly® reagents, and Vmax™ chemically competent cells.
In addition to automating, speeding, and optimizing DNA design and synthesis, Codex DNA and the BioXp™ system ensure your designs stay in your hands, marrying speed and security for innovators in drug discovery, vaccine development, precision medicine, and beyond.
Co-founded by Dan Gibson — the creator of the industry-standard Gibson Assembly® methodology — Codex DNA is attempting nothing less than changing everything.
Codex DNA is committed to best practices in biosecurity and is a member of the International Gene Synthesis Consortium. We support researchers and the synthetic biology community with the responsible synthesis of genes for discovering and creating new medicines, diagnostic tests, agricultural biotechnology products, industrial chemicals, and other beneficial applications.